Back
EHRA Premium Access

Evaluation of the impact of a CTO on VAs and long-term mortality in patients with ICM and an ICD (the eCTOpy-in-ICD study)

Session: Shocking truths regarding implantable cardioverter defibrillators
Topic: Implantable Cardioverter / Defibrillator
Speaker: Mr I. van Dongen (Amsterdam, NL)
Event: EHRA 2018

Congress Presentation

Add to my library

Like

About the speaker

Mr Ivo van Dongen

Academic Medical Centre, Amsterdam (Netherlands (The))
0 follower

8 more presentations in this session

Striking difference between cardiac sub-specialties during consideration for implantable cardioverter defibrillators

Speaker: Doctor A. Mistry (Leicester, GB)

Access
Abstract
Slides
Video
Like
Thumbnail

The destiny of abandoned transvenous ICD leads

Speaker: Mr A. Elgaard (Aalborg, DK)

Access
Abstract
Like
Thumbnail

FRAGILE (French Attitude Registry in case of ICD Lead Replacement) preliminary results.

Speaker: Doctor C. Alonso (Neuilly sur Seine, FR)

Access
Abstract
Slides
Video
Like
Thumbnail

Predictors and clinical impact of late ventricular arrhythmias in patients with continuous-flow left ventricular assist devices.

Speaker: Doctor V. Galand (Rennes, FR)

Access
Abstract
Like
Thumbnail

Single chamber implantable cardioverter defibrillator compared to dual chamber implantable cardioverter defibrillator. Less is more. Data from the German Device Registry

Speaker: Doctor H. Bogossian (Hagen, DE)

Access
Abstract
Like
Thumbnail

Access the full session

Shocking truths regarding implantable cardioverter defibrillators

Speakers: Mr I. van Dongen, Doctor A. Mistry, Mr A. Elgaard, Doctor C. Alonso, Doctor V. Galand...
Access
Like
Thumbnail

About the event

Image

EHRA 2018

18 March - 20 March 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources